课题基金 / 基金详情

8TH INTERNATIONAL SYMPOSIUM ON CHLAMYDIAL INFECTION

8TH INTERNATIONAL SYMPOSIUM ON CHLAMYDIAL INFECTION
第八届衣原体感染国际研讨会
批准号:
2071543
负责人:
JULIUS SCHACHTER
金额:
$0.75万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-06-01 至 1994-11-30

项目摘要

项目成果

JULIUS SCHACHTER的其他基金

相似基金

相关文献

中文摘要
翻译
目前正在寻求对第八届人类住区国际专题讨论会的支持, 衣原体感染。 这些生物是最普遍的 人类病原体 沙眼衣原体是世界上导致 可预防的失明和我们最常见的性传播细菌 对受影响的男性、女性和新生儿造成严重后果的病原体 婴儿。 C.肺炎被认为是一种非常常见的呼吸道疾病, 病原体,最近与慢性呼吸道疾病有关 和冠心病。 随着近年来诊断和 治疗,很可能是重要的进展是迫在眉睫的控制 性传播的衣原体和沙眼。 现代技术在 分子生物学已经帮助并将继续帮助进一步 衣原体疾病的临床特征。 随着近期 关于这些生物的信息爆炸,是时候另一个了。 在一系列关于这一问题的定期国际会议上。 先前 这些会议的成功证明了这一场所的价值, 交流信息和比较不同国家的结果。 这些会议继续为新的研究提供动力。
英文摘要
Support is being sought for the Eighth International Symposium on Human Chlamydial Infections. These organisms are among the most prevalent of human pathogens. Chlamydia trachomatis is the world's leading cause of preventable blindness and our most common sexually transmitted bacterial pathogen with serious consequences to affected men, women, and newborn infants. C. pneumoniae is recognized as a very common respiratory pathogen and has recently been implicated in chronic respiratory disease and coronary artery disease. With recent advances in diagnosis and therapeutics, it is likely that important advances are imminent in control of sexually transmitted chlamydiae and trachoma. Modern techniques in molecular biology have aided and will continue to help in further characterizing clinical spectrum of chlamydial disease. With the recent explosion of information on these organisms, the time is right for another in a series of periodic international meetings on the subject. Previous success of these meetings has attested to the value of this venue for exchanging information and comparison of results in different countries. These meetings have continued to provide impetus for new research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
12th International Symposium on Human Chlamydial Infections
Xlth International Symposium on Human Chlamydial Infections
Xth Int'l Symposium on Human Chlamydial Infection
Azithromycin in Control of Trachoma II
海外基金